245 mg tablets
co formulated with emtricitabine as Truvada
co formulated with efavirenz and emtricitabine as Atripla
co formulated with emtricitabine and rilpivirine as Eviplera
co formulated with cobicistat, elvitegravir, and emtricitabine as Stribild
Infant 13 mg/kg as a single dose within 12 hours of life.
Potential to impair renal function
Avoid other nephrotoxic medication
Test renal function and serum phosphate before treatment, then every 4 weeks (more frequently if at increased risk of renal impairment) for 1 year and then every 3 months, interrupt treatment if renal function deteriorates or serum phosphate decreases.
Active against hepatitis B, risk of flare if treatment interupted
FDA catagery B
Tenofovir should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.